Lucas Viana Gomes Silva

Immunomodulatory activity of trifluoromethyl arylamides derived from the SRPK inhibitor SRPIN340 and their potential use as vaccine adjuvant.

G. Bressan, J. Fietto, L. D. de Oliveira, 2022, Life sciences.